MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20243217

February 23, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1%(5ml: 5mg)

化学药品

February 23, 2024

Company Information

Applicant Company

江西省南昌市高新开发区京东北大道399号

Manufacturing Company

江西省南昌市高新开发区京东北大道399号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath